Sylvia Kurz

11PUBLICATIONS
75CO-AUTHORS
Gene and molecular therapyCancer therapy (excl. chemotherapy and radiation therapy)Molecular targetsCellular nervous systemHaematological tumours
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (11)

|Mar 24, 2026
Clinical outcome of biomarker-guided therapies in adult neuro-oncology patients: An update from the Tübingen molecular tumor board cohort.

David Rieger, Hannes Becker, Bianca Walter

|Sep 22, 2025
Assessing the clinical benefit from medical therapies in CNS malignancies: Refining the ESMO Magnitude of Clinical Benefit Scale and the ASCO Value Framework.

Sylvia C Kurz, Mirjam Renovanz, Michael Bitzer

|Feb 09, 2024
ONC201 (Dordaviprone) in Recurrent H3 K27M-Mutant Diffuse Midline Glioma.

Isabel Arrillaga-Romany, Sharon L Gardner, Yazmin Odia

|Dec 04, 2023
Evaluation of the SSTR2-targeted Radiopharmaceutical 177Lu-DOTATATE and SSTR2-specific 68Ga-DOTATATE PET as Imaging Biomarker in Patients with Intracranial Meningioma.

Sylvia C Kurz, Elcin Zan, Christine Cordova

|Sep 22, 2023
Towards more Diversity in Neuro-oncology Leadership-the DivINe Initiative.

Sylvia C Kurz, Anja Stammberger, Steffen K Rosahl

|Aug 01, 2023
Association of MTHFR Polymorphisms With Leukoencephalopathy Risk in Patients With Primary CNS Lymphoma Treated With Methotrexate-Based Regimens.

Philipp Karschnia, Sylvia C Kurz, Priscilla K Brastianos

Pageof 2

Frequent Collaborators

3 joint publications

Ghazaleh Tabatabai

3 joint publications

Mirjam Renovanz

2 joint publications

Marcos Tatagiba

2 joint publications

Maximilian Niyazi